Skip to main content
Log in

Antirheumatic drugs ands macrophage function: Effects on tumour cell crowth in vitro

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

The ability of the antirheumatic drugs D-penicillamine, chloroquine and levamisole to modify macrophage-mediated inhibition of tumour cell growth in vitro was investigated. Increasing numbers of rat peritoneal macrophages were cocultured with a fixed number of ascites hepatoma AH-13 rat tumour cells. Tumour cell growth was assessed as the uptake of3H-thymidine (3H-TdR) by AH-13 cells at the end of a 24h period of coculture with macrophages treated in vitro or in vivo with the various drugs. In vitro, preincubation of macrophages with D-penicillamine or chloroquine (50 – 250 μg/ml) increased tumour cell3H-TdR incorporation, compared to cultures with untreated macrophages. Macrophages from rats treated with D-penicillamine or chloroquine (50 mg/kg/day orally) for 4 days similarly increased tumour cell3H-TdR incorporation, compared to cultures with macrophages from untreated rats. These effects persisted for at least 3 to 4 weeks of treatment. Preincubation with levamisole (10 – 100 μg/ml) in vitro had no effect on macrophage-mediated inhibition of tumour cells, whereas increased tumour cell3H-TdR incorporation was observed in cultures with macrophages from rats treated with levamisole (5 mg/kg/day orally) in vivo. Macrophages from rats with experimentally induced chronic inflammation, i.e. adjuvant arthritis, were found to increase tumour cell3H-TdR incorporation, compared to macrophages from nonarthritic rats. This trend was further enhanced by treatment with D-penicillamine, chloroquine or levamisole.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Reference

  1. Paget, S.A. and Gibofsky, A. Immunopathogenesis of rheumatoid arthritis. Am. J. Med. 1979,67, 961–970.

    Article  PubMed  Google Scholar 

  2. Janossy, G., Duke, O., Poulter, L.W., Panayi, G., Bofill, M. and Goldstein, G. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet 1981,2, 839–842.

    Article  PubMed  Google Scholar 

  3. Jaffe, I.A. The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthritis Rheum. 1970,13, 436–443.

    PubMed  Google Scholar 

  4. De Cree, J. and Symoens, J. Immunological profile of levamisole and its clinical application in man. In: Drugs and immune responsiveness. Editors: Turk, J.L. and Parker, D., The MacMillan Press Ltd., London, 1979, 85–117.

    Google Scholar 

  5. Kahn, M.F. Medical treatment of chronic inflammatory rheumatic diseases. Scand. J. Rheumatol. 1975, suppl.12, 97–104.

    Google Scholar 

  6. Binderup, L., Bramm, E. and Arrigoni-Martelli, E. D-penicillamine and macrophages: modulation of lymphocyte transformation by Concanavalin A. Scand. J. Immunol. 1978,7, 259–264.

    PubMed  Google Scholar 

  7. Binderup, L., Bramm, E. and Arrigoni-Martelli, E. D-penicillamine in vivo enhances lymphocyte DNA-synthesis: role of macrophages. Scand. J. Immunol. 1980,11, 23–28.

    PubMed  Google Scholar 

  8. Binderup, L., Bramm, E. and Arrigoni-Martelli, E. Effect of D-penicillamine in vitro and in vivo on macrophage phagocytosis. Biochem. Pharmacol. 1980,29, 2273–2278.

    Article  PubMed  Google Scholar 

  9. Binderup, L., Bramm, E. and Arrigoni-Martelli, E. The effect of some antirheumatic drugs in vivo on the response of spleen cells to Concanavalin A in rats with chronic inflammation. Int. J. Immunopharmacol. 1981, in press.

  10. Riches, D.W., Morris, C.J. and Stanworth, D.R. Induction of selective acid hydrolase release from mouse macrophages during exposure to chloroquine and quinine. Biochem. Pharmacol. 1981,30, 629–634.

    Article  PubMed  Google Scholar 

  11. Symoens, J. and Rosenthal, M. Levamisole in the modulation of the immune response. J. Reticuloendothel. Soc. 1977,21, 175–221.

    PubMed  Google Scholar 

  12. Binderup, L., Bramm, E. and Arrigoni-Martelli, E. Peritoneal macrophages from adjuvant arthritic rats enhance tumour cell growth in vitro. Experientia 1979,35, 1230–1231.

    Article  PubMed  Google Scholar 

  13. Pearson, C.M. Experimental models in rheumatoid disease. Arthritis Rheum. 1964,7, 80–86.

    Google Scholar 

  14. Yam, L.T., Li, C.Y. and Crosby, W.H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol 1971,55, 283–290.

    PubMed  Google Scholar 

  15. Yoshida, T. Comparative studies of ascites hepatomas. Meth. Cancer Res. 1971,1, 97–156.

    Google Scholar 

  16. Cameron, D.J. and Hallowell Churchill, W. Macrophage mediated cytotoxicity in man: role of hydrocortisone, trypan blue, chloroquine and prednisolone. Int. J. Immunopharmacol. 1981,3, 77–85.

    Article  PubMed  Google Scholar 

  17. Binderup, L. and Arrigoni-Martelli, E. [14C]-D-penicillamine: uptake and distribution in rat lymphocytes and macrophages. Biochem. Pharmacol. 1979,28, 189–192.

    Article  PubMed  Google Scholar 

  18. Hunneyball, I.M., Stewart, G.A. and Stanworth, D.R. The effects of oral D-penicillamine treatment on experimental arthritis and the associated immune response in rabbits. Immunology 1978.35, 159–166.

    PubMed  Google Scholar 

  19. Sehgal, P.B., Tamm, I. and Vilcek, J. Enhancement of human interferon production by neutral red and chloroquine, J. Exp. Med. 1975,142, 1283–1300.

    Article  PubMed  Google Scholar 

  20. Ginckel R. van and Debrabander, M. The influence of a levamisole metabolite (DL-2-oxo-3-[2-mercapthoethyl]-5-phenylimidazoline) on carbon clearance in mice. J. Reticuloendothel. Soc. 1979,25, 125–131.

    PubMed  Google Scholar 

  21. Sampson, D. and Lui, A. The effect of levamisole on cell-mediated immunity and suppressor-cell function. Cancer Res. 1976,36, 952–955.

    PubMed  Google Scholar 

  22. Chang, Y., Pearson, C.M. and Abe, C. Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathological, and other studies. Arthritis Rheum. 1980,23, 62–71.

    PubMed  Google Scholar 

  23. Mantovani, A., Jerrells, T.R., Dean, J.H. and Herberman, R.B. Cytolytic and cytostatic activity on tumor cells of circulating human monocytes. Int. J. Cancer 1979,23, 18–27.

    PubMed  Google Scholar 

  24. Haller, O., Hansson, M., Kiessling, R. and Wigzell, H. Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature 1977,270, 609–611.

    Article  PubMed  Google Scholar 

  25. Kirchner, H., Holden, H.T. and Herberman, R.B. Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum. J. Immunol. 1975,115, 1212–1216.

    PubMed  Google Scholar 

  26. Cerrottini, J.C., Nordin, A.A. and Brunner, K.T. Specific in vitro cytotoxicity of thymus derived lymphocytes sensitized to alloantigens. Nature 1970,228, 1308–1309.

    Article  PubMed  Google Scholar 

  27. Matsubara, S., Suzuki, M., Suzuki, F. and Ishida, N. The induction of viral inhibitor(s) in mice treated with biological and synthetic immunopotentiators. Microbiol. Immunol. 1980,24, 87–90.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Binderup, L., Bramm, E. & Arrigoni-Martelli, E. Antirheumatic drugs ands macrophage function: Effects on tumour cell crowth in vitro. Clin Rheumatol 1, 15–22 (1982). https://doi.org/10.1007/BF02032471

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02032471

Key-words

Navigation